HomeAI in HealthIn vivo clinical efficacy of artificial intelligence screening for acute coronary syndrome:...

In vivo clinical efficacy of artificial intelligence screening for acute coronary syndrome: testing performance in real-world conditions

Revolutionizing Emergency Department Care with Predictive Models

In the rapidly evolving landscape of healthcare, predictive models are pioneering a path toward more precise and efficient patient care. Despite the numerous models introduced, their integration into clinical practice remains limited, often leaving their real-world performance unexplored. A recent initiative seeks to bridge this gap by deploying a prediction model in a clinical setting, aiming to enhance the diagnosis of acute coronary syndrome (ACS) in emergency departments.

Leveraging Predictive Models for Acute Coronary Syndrome

This innovative approach involved training a prediction model to achieve two primary objectives: first, to estimate the risk of ACS in patients upon their arrival at the emergency department, and second, to identify those at highest risk of ST-segment myocardial infarction (STEMI) who would benefit from an early electrocardiogram (ECG). By integrating the model as a clinical decision support system (CDS), a silent pilot was conducted using real-world data, marking a significant step in testing the model’s effectiveness outside of controlled environments.

Methods and Analysis

The study was conducted between November 2023 and April 2024, prospectively analyzing every patient visit to the emergency department. The CDS calculated each patient’s ACS risk and determined the necessity for an early ECG, ensuring that the total number of ECGs performed did not exceed the traditional standard of approximately 33%. By employing raw agreement and Cohen’s kappa, the screening decisions made by the CDS were compared to those of the original in vitro model. Sensitivity and specificity for ACS were the primary metrics of interest, providing a basis for comparison with human screening decisions.

Results

During the study period, 32,346 patient visits were processed by the CDS. Of these, 1.0% were diagnosed with ACS and 0.1% with STEMI. The agreement between the CDS and the original model was remarkably high, with a pure agreement rate of 96.8% and a kappa value of 91.2% (95% CI 90.7% to 91.8%). The sensitivity for detecting ACS was 81.7% (95% CI 77.1% to 85.8%) using the CDS, compared to 80.2% (95% CI 75.4% to 84.4%) by human evaluators. The specificity was nearly identical between the two methods, at 67.3% (95% CI 66.8% to 67.9%) for the CDS and 67.4% (95% CI 66.9% to 67.9%) for human assessment.

Conclusion

The study demonstrates a high level of agreement and consistency in screening performance between the CDS and the original predictive model, with sensitivity and specificity rates closely mirroring those of human practice. This suggests that CDS can effectively replicate model performance in real-world settings, although some discrepancies remain. Quantifying these differences is crucial in estimating the true impact of predictive models prior to their broader deployment in clinical environments.

The findings underscore the potential of CDS to enhance decision-making processes in emergency care, promising a future where predictive models are seamlessly integrated into clinical workflows. For more in-depth information on this study, visit the source link Here.

“`

Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here